Interestingly, the knockdown of ERBB3/HER3, a receptor linked with prostate cancer, in DU-145 cells culminated in EphA4 downregulation, suggesting that ERBB3/HER3 regulates EphA4 levels, as shown by Soler et al. [94]. Here, EPHA4 is linked to prostate carcinoma.